Common questions about Aerius (FAQ)
Q: Is Aerius generally considered to be a non-drowsy medication?
A: Official documents describe this medicine as a non-sedating, second-generation antihistamine. This is because the active ingredient has minimal ability to cross the blood-brain barrier. The incidence of drowsiness in many clinical studies was reported to be similar to the rates seen with placebo.
Q: Can Aerius be taken alongside common pain relievers?
A: Clinical studies have investigated interactions between the active ingredient and specific medications. Official documents have not reported known interactions with common pain-relieving ingredients such as ibuprofen or acetaminophen. Official guidance emphasizes informing a healthcare provider about all prescription and over-the-counter medicines being taken.
Q: Can Aerius cause dry mouth or drowsiness?
A: Official safety information reports dry mouth as a common side effect, which means it may occur in up to 1 in 10 patients. Drowsiness, or somnolence, is classified as a very rare effect, occurring in less than 1 in 10,000 patients.
Q: Is Aerius available without a prescription in some places?
A: The legal availability of this medicine is determined by the specific regulations of each country or region. Therefore, the status of the medicine—whether it is available over-the-counter (OTC) or requires a prescription—can vary depending on your location.
Q: Are there any specific foods or drinks to avoid while taking Aerius?
A: Official information states that the medicine may be taken with or without food. Official guidance recommends caution regarding alcohol consumption due to post-marketing reports of alcohol intolerance or intoxication.
Q: Can Aerius be taken by people with kidney or liver issues?
A: Caution is noted in official documents for patients with severe kidney or liver impairment. For adults with these specific conditions, official guidelines describe a modified starting dose (e.g., taking the medicine every other day) based on how the body processes the drug.
Q: What should be done in the event of taking too much Aerius?
A: In the event of an overdose, the types of side effects observed are similar to those at therapeutic doses, but the effects may be more pronounced. Measures to remove unabsorbed active substance and providing symptomatic and supportive treatment are the standard medical considerations.
Q: Are there any known interactions between Aerius and herbal supplements?
A: Official labeling advises patients to inform their healthcare provider about all herbal supplements they are taking. There is generally limited specific data reported in regulatory sources regarding interactions between the active ingredient and herbal remedies.
Q: Are there any specific symptoms that indicate Aerius is not right for a person?
A: Official labeling indicates that the medicine should be stopped, and immediate medical attention sought, if certain severe symptoms occur. These may include signs of a severe allergic reaction (such as swelling of the face, lips, or throat) or other serious events like seizures or liver dysfunction (jaundice).
Q: How is Aerius different from other desloratadine products?
A: Aerius contains the active ingredient desloratadine. Other medicines containing desloratadine are often generic versions that are proven to be bioequivalent. This means they contain the same amount of active substance and are expected to produce the same effect as the brand-name product.
Q: What does official guidance say about using Aerius with other allergy medicines?
A: Official guidance notes that co-administration with other central nervous system depressants (medicines that slow brain activity) should be discussed with a healthcare provider. This is because combining certain medicines, which may include some sedating allergy medications, could increase the risk of sedation.
Q: What official information is available regarding the long-term use of Aerius?
A: For patients who experience symptoms persistently, continued administration of the medicine may be maintained during allergen exposure periods. Regulatory bodies periodically assess long-term safety; for instance, a safety review found no established link between the medicine and an abnormal heart rhythm.
Q: What does the term 'non-sedating' mean when applied to Aerius?
A: The term 'non-sedating' is used because the medicine is a selective antagonist that has a limited ability to cross the blood-brain barrier. This means its activity is largely confined to peripheral body tissues, minimizing interaction with histamine receptors in the central nervous system.
Q: Does Aerius require a dose adjustment for elderly patients?
A: Official prescribing information indicates that no specific dosage adjustment is required for older adults or the elderly. However, older patients are more likely to have co-existing kidney or liver issues, and those conditions may necessitate a dose modification.
Q: Why might a doctor prescribe Aerius instead of a first-generation antihistamine?
A: Official documents classify this medicine as a second-generation H1-antihistamine. This class of medicine is recognized for its peripheral selectivity and minimal blood-brain barrier penetration, which are associated with a reduced potential for causing sleepiness compared to some first-generation antihistamines.
Q: What are the most common reasons people stop taking Aerius?
A: Patients are instructed to stop taking the medicine if a severe allergic reaction occurs. The most common side effects reported in clinical trials that occurred more frequently than with a placebo included pharyngitis (sore throat), dry mouth, muscle pain (myalgia), and fatigue.
Q: What are the general expectations for relief when taking Aerius?
A: The medicine is intended to provide sustained relief over a 24-hour cycle from symptoms associated with allergic rhinitis and urticaria. This relief from symptoms like sneezing, itching, hives, and runny nose may help support normal daily activities and sleep.
